Literature DB >> 29319276

Pathways in melanoma development.

Tal H Erlich1, David E Fisher2,3.   

Abstract

This review aimed to summarize the current advances in melanoma research and their clinical relevance. Until recently, melanoma was considered an incurable disease. However, in recent years tremendous advances have been made in therapeutics. This is due to profound understanding of the molecular pathways involved in melanoma development. Although new targets are always emerging, understanding how to overcome resistance to current treatments is of great interest.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29319276     DOI: 10.23736/S0392-0488.17.05795-9

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


  3 in total

Review 1.  Model Systems for the Study of Malignant Melanoma.

Authors:  Randal K Gregg
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Cutaneous Melanoma-A Long Road from Experimental Models to Clinical Outcome: A Review.

Authors:  Dorina Coricovac; Cristina Dehelean; Elena-Alina Moaca; Iulia Pinzaru; Tiberiu Bratu; Dan Navolan; Ovidiu Boruga
Journal:  Int J Mol Sci       Date:  2018-05-24       Impact factor: 5.923

3.  ROCK inhibitor enhances the growth and migration of BRAF-mutant skin melanoma cells.

Authors:  Fei Chang; Yunpeng Zhang; Jun Mi; Qian Zhou; Fuxiang Bai; Xin Xu; David E Fisher; Qinfeng Sun; Xunwei Wu
Journal:  Cancer Sci       Date:  2018-09-23       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.